Rosiglitazone Prior Authorization Safety Policy: A Cohort Study

BACKGROUND: Prior authorizations (PA) are intended to promote safe and cost-effective medication use. Unwanted outcomes may occur, however, such as a patient forgoing drug therapy after a PA. The label for rosiglitazone was revised in November 2007 to include the warning of contraindicated use with...

Descripción completa

Detalles Bibliográficos
Autores principales: Starner, Catherine I., Fenrick, Beckie, Coleman, John, Wickersham, Peter, Gleason, Patrick P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437465/
https://www.ncbi.nlm.nih.gov/pubmed/22468731
http://dx.doi.org/10.18553/jmcp.2012.18.3.225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437465/
https://www.ncbi.nlm.nih.gov/pubmed/22468731
http://dx.doi.org/10.18553/jmcp.2012.18.3.225

Ejemplares similares